COVID-19 | GILEAD

Gilead’s Response to COVID-19 Gilead is focused on deploying our resources and decades of antiviral expertise to help patients and communities fighting the COVID-19 pandemic. As a pioneer and leader in antiviral drug development, Gilead developed the first antiviral drug approved to treat COVID-19 and continues to invest in this medicine and research that will prepare us for emerging pandemic thre

[powerhouse63w]

レムデシビルの会社。1月まで5000人分、3月まで3万人分のレムデシビルしか作ったことがなかったが、今後1年で月産数十万人分まで製造能力を上げる予定。富山化学より若干野心的な製造計画。